In vitro anti-cancer activity of two ethno-pharmacological healing plants from Guatemala Pluchea odorata and Phlebodium decumanum

International Journal of Oncology

Volumn 34, Issue 4, 2009, Pages 1117-1128

  Gridling, Manuela ^a   Stark, Nicole ^a   Madlener, Sibylle ^a   Lackber, Andreas ^a   Popescu, Ruxandra ^b   Benedek, Birgit ^b   Diaz, Rene ^c   Tut, Foster M ^c   Nha Vo, Thanh Phuong ^a,b   Huber, Daniela ^a   Gollinger, Michaela ^a   Saiko, Philipp ^a   Özmen, Ali ^d   Mosgoeller, Wilhelm ^a   de Martin, Rainer ^a   Eytner, Ruth ^a   Wagner, Karl Heinz ^b   Grusch, Michael ^a   Fritzer Szekeres, Monika ^a   Szekeres, Thomas ^a   Kopp, Brigitte ^b   Frisch, Richard ^c   Krupitza, Georg ^a   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Institute for Ethnobiology   (Guatemala)

^d ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Anti inflammatory; Anti neoplastic; Apoptosis; Cell cycle arrest; Pluchea odorata

Indexed keywords

ALPHA TUBULIN; CASPASE 3; CHECKPOINT KINASE 2; CYCLIN D1; HERBACEOUS AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PHLEBODIUM DECUMANUM EXTRACT; PLUCHEA ODORATA EXTRACT; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL PROLIFERATION; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFICACY; DRUG ISOLATION; ENZYME ACTIVATION; ENZYME INACTIVATION; GUATEMALA; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MEDICINAL PLANT; MICROTUBULE; MITOSIS INHIBITION; PHLEBODIUM DECUMANUM; PLUCHEA ODORATA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SOLVENT EXTRACTION;

ANTINEOPLASTIC AGENTS; ASTERACEAE; BISBENZIMIDAZOLE; CELL LINE, TUMOR; CELL SEPARATION; DRUG SCREENING ASSAYS, ANTITUMOR; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHNOPHARMACOLOGY; FLOW CYTOMETRY; GUATEMALA; HL-60 CELLS; HUMANS; PLANT EXTRACTS; SUBCELLULAR FRACTIONS;

EID: 67649443786     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000239     Document Type: Article

References (45)

1. Cragg GM and Newman DJ: Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 9: 2783-2797, 2000.
2. Cragg GM, Newman DJ and Yang SS: Natural product extracts of plant and marine origin having antileukemia potential. The NCI experience (Review). J Nat Prod 69: 488-498, 2006.
3. Bolsover SR, Hyams JS, Shephard EA, White HA and Wiedemann CG: Cell biology: a short course. John Wiley & Sons, Inc., Hoboken, New Jersey, 2004.
4. Ribeiro LR, Mantovani MS, Ribeiro DA and Salvadori DM: Brazilian natural dietary components (annatto, propolis and mushrooms) protecting against mutation and cancer (Review). Hum Exp Toxicol 25: 267-272, 2006.
5. Rakoff-Nahoum S: Why cancer and inflammation? (Review). Yale J Biol Med 79: 123-130, 2006.
6. Federico A, Morgillo F, Tuccillo C, Ciardiello F and Loguercio C: Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381-2386, 2007.
7. Hold GL and El-Omar ME: Genetic aspects of inflammation and cancer (Review). Biochem J 410: 225-235, 2008.
8. Geney R, Sun L, Pera P, Bernacki RJ, Xia S, Horwitz SB, Simmerling CL and Ojima I: Use of the tubulin bound paclitaxel conformation for structure-based rational drug design. Chem Biol 12: 339-348, 2005.
9. Marcus AI, Zhou J, O'Brate A, Hamel E, Wong J, Nivens M, El-Naggar A, Yao TP, Khuri FR and Giannakakou P: The synergistic combination of the farnesyl transferase inhibitor lonafarnib and paclitaxel enhances tubulin acetylation and requires a functional tubulin deacetylase. Cancer Res 65: 3883-3893, 2005.
10. Piperno G, LeDizet M and Chang XJ: Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104: 289-302, 1987.
11. Piperno G and Fuller M: Monoclonal antibodies specific for an acetylated form of alpha-tubulin recognize the antigen in cilia and flagella from a variety of organisms. J Cell Biol 101: 2085-2094, 1985.
12. Grusch M, Polgar D, Gfatter S, Leuhuber K, Huettenbrenner S, Leisser C, Fuhrmann G, Kassie F, Steinkellner H, Smid K, Peters GJ, Jayaram HN, Klepal W, Szekeres T, Knasmuller S and Krupitza G: Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death Differ 9: 169-178, 2002.
13. Huettenbrenner S, Maier S, Leisser C, Polgar D, Strasser S, Grusch M and Krupitza G: The evolution of cell death programs as prerequisites of multicellularity (Review). Mutat Res 543: 235-249, 2003.
14. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
15. Wilson PJ and Forer A: Effects of nanomolar taxol on crane-fly spermatocyte spindles indicate that acetylation of kinetochore microtubules can be used as a marker of poleward tubulin flux. Cell Motil Cytoskeleton 37: 20-32, 1997.
16. Arvigo R and Balick M: Rainforest Remedies. Lotus Press, Twin Lakes, WI, 1998.
17. Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
18. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80: 225-236, 1995.
19. Hill CS and Treisman R: Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80: 199-211, 1995.
20. Cowley S, Paterson H, Kemp P and Marshall CJ: Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852, 1994.
21. Sturgill TW, Erikson LBRE and Maller JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334: 715-718, 1988.
22. Payne DM, Rossomando AJ, Martino P. Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ and Sturgill TW: Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10: 885-892, 1991.
23. Alao JP: The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24, 2007.
24. Lingfei K, Pingzhang Y, Zhengguo L, Jianhua G and Yaowu Z: A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers. Cancer Lett 130: 93-101, 1998.
25. Xiong Y, Zhang H and Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 504-514, 1992.
26. Xiong Y, Menninger J, Beach D and Ward DC: Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins. Genomics 13: 575-584, 1992.
27. Inaba T, Matsushime J, Beach D and Ward DC: Genomic organization, chromosomal localization, and independent expression of human cyclin D genes. Genomics 13: 565-574, 1992.
28. Alonso-Lopez M, Arriaga-Giner FJ, Borges-del-Castillo J and Vasquez-Bueno P: N-alkanes and triterpenoids from some Salvadorian compositae. Fitoterapia 56: 123-125, 1985.
29. Wollenweber E, Mann K, Arriaga FJ and Yatskievych G: Flavonoids and terpenoids from the leaf resin of Pluchea odorata. J Biosciences 40C: 321-324, 1985.
30. Arriaga FJ and Borges-del-Castillo J: A new eudesmane derivative from Pluchea odorata. Planta Med 51: 290, 1985.
31. Arriaga FJ and Borges-del-Castillo J: Carbon-13 NMR spectra of Plucheinol and its ester derivatives. Magn Res Chem 23: 478-488, 1985.
32. Bader Y, Madlener S, Strasser S, Maier S, Saiko P, Stark N, Popescu R, Huber D, Gollinger M, Erker T, Handler N, Szakmary A, Jäger W, Kopp B, Tentes I, Fritzer-Szekeres M, Krupitza G and Szekeres T: Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Oncol Rep 19: 801-810, 2008.
33. Madlener S, Illmer C, Horvath Z, Saiko P, Losert A, Herbacek I, Grusch M, Elford HL, Krupitza G, Bernhaus A, Fritzer-Szekeres M and Szekeres T: Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells. Cancer Lett 245: 156-162, 2007.
34. Saiko P, Ozsvar-Kozma M, Bernhaus A, Jaschke M, Graser G, Lackner A, Grusch M, Horvath Z, Madlener S, Krupitza G, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M and Szekeres T: N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine. Int J Oncol 31: 1261-1266, 2007.
35. Horvath Z, Murias M, Saiko P, Erker T, Handler N, Madlener S, Jaeger W, Grusch M, Fritzer-Szekeres M, Krupitza G and Szekeres T: Cytotoxic and biochemical effects of 3,3′,4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp Hematol 34: 1377-1384, 2006.
36. Grusch M, Fritzer-Szekeres M, Fuhrmann G, Rosenberger G, Luxbacher C, Elford HL, Smid K, Peters GJ, Szekeres T and Krupitza G: Activation of caspases and induction of apoptosis by novel ribonucleotide reductase inhibitors amidox and didox. Exp Hematol 29: 623-632, 2001.
37. Rosenberger G, Fuhrmann G, Grusch M, Fassl S, Elford HL, Smid K, Peters GJ, Szekeres T and Krupitza G: The ribonucleotide reductase inhibitor trimidox induces c-myc and apoptosis of human ovarian carcinoma cells. Life Sci 67: 3131-3142, 2000.
38. Fritzer-Szekeres M, Grusch M, Luxbacher C, Horvath S, Krupitza G, Elford HL and Szekeres T: Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cells. Exp Hematol 28: 924-930, 2000.
39. Jordan MA and Wilson L: Microtubules as a target for anticancer drugs (Review). Nat Rev Cancer 4: 253-265, 2004.
40. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H, Komatsu Y, Nishino N, Khochbin S, Horinouchi S and Yoshida M: In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 21: 6820-6831, 2002.
41. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF and Yao TP: HDAC6 is a microtubule-associated deacetylase. Nature 23;417: 455-458, 2002.
42. Crespo NC, Delarue F, Ohkanda J, Carrico D, Hamilton AD and Sebti SM: The farnesyl-transferase inhibitor, FTI-2153, inhibits bipolar spindle formation during mitosis independently of transformation and Ras and p53 mutation status. Cell Death Differ 9: 702-709, 2002.
43. Weinstein JN, Myers TG, O'Connor PM, Friend SH, Fornace AJ Jr, Kohn KW, Fojo T, Bates SE, Rubinstein LV, Anderson NL, Buolamwini JK, van Osdol WW, Monks AP, Scudiero DA, Sausville EA, Zaharevitz DW, Bunow B, Viswanadhan VN, Johnson GS, Wittes RE and Paull KD: An information-intensive approach to the molecular pharmacology of cancer. Science 275: 343-349, 1997.
44. Dominguez XA and Zamudio A: β-amyrin acetate and campestereol from Pluchea odorata. Phytochemistry 11: 1179, 1972.
45. Arriaga-Giner FJ, Borges-del-Castillo J, Manresa-Ferrero MT, Vasquez-Bueno P, Rodriguez-Luis F and Valdes-Iraheta S: Eudesmane derivatives from Pluchea odorata. Phytochemistry 22: 1767-1769, 1983.